This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated with improved survival in both newly diagnosed & recurrent glioblastoma compared with matched controls who received SOC treatment.
@MountSinaiNeuro
@UCLANsgy
Unfortunately there is very little media coverage of this incredible medical breakthrough, which is quite disturbing. Please spread the word as people right now could have their one and ONLY LIFE prolonged and not have to suffer the effects of Chemo.